Jacobson & Schmitt Advisors LLC Boosts Position in Danaher Corporation $DHR

Jacobson & Schmitt Advisors LLC increased its position in Danaher Corporation (NYSE:DHR) by 2.9% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 94,734 shares of the conglomerate’s stock after purchasing an additional 2,628 shares during the period. Danaher makes up 3.3% of Jacobson & Schmitt Advisors LLC’s investment portfolio, making the stock its 8th largest holding. Jacobson & Schmitt Advisors LLC’s holdings in Danaher were worth $18,714,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. MGO One Seven LLC raised its position in Danaher by 485.7% in the 1st quarter. MGO One Seven LLC now owns 25,098 shares of the conglomerate’s stock valued at $5,145,000 after buying an additional 20,813 shares during the last quarter. Chicago Capital LLC raised its position in Danaher by 11.6% in the 2nd quarter. Chicago Capital LLC now owns 13,332 shares of the conglomerate’s stock valued at $2,634,000 after buying an additional 1,391 shares during the last quarter. UniSuper Management Pty Ltd raised its position in Danaher by 1.6% in the 1st quarter. UniSuper Management Pty Ltd now owns 170,505 shares of the conglomerate’s stock valued at $34,954,000 after buying an additional 2,667 shares during the last quarter. Asahi Life Asset Management CO. LTD. purchased a new stake in Danaher in the 1st quarter valued at $539,000. Finally, ASR Vermogensbeheer N.V. raised its position in Danaher by 1.9% in the 2nd quarter. ASR Vermogensbeheer N.V. now owns 322,924 shares of the conglomerate’s stock valued at $63,787,000 after buying an additional 6,136 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In related news, Director Teri List sold 2,778 shares of Danaher stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the sale, the director owned 20,751 shares of the company’s stock, valued at approximately $4,379,706.06. This trade represents a 11.81% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Company insiders own 11.10% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on DHR shares. Wells Fargo & Company reissued a “positive” rating on shares of Danaher in a research report on Thursday, October 23rd. Wall Street Zen raised Danaher from a “hold” rating to a “buy” rating in a research report on Sunday. Guggenheim reaffirmed a “buy” rating and set a $250.00 target price on shares of Danaher in a research report on Wednesday, July 23rd. Redburn Partners set a $220.00 target price on Danaher in a research report on Wednesday, October 8th. Finally, Robert W. Baird set a $247.00 target price on Danaher in a research report on Wednesday, October 22nd. Eighteen equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $243.39.

Danaher Trading Down 0.1%

Shares of Danaher stock opened at $213.89 on Wednesday. The stock has a fifty day moving average price of $203.68 and a 200-day moving average price of $199.98. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $258.23. The firm has a market cap of $151.08 billion, a PE ratio of 44.10, a P/E/G ratio of 3.28 and a beta of 0.77. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.52 and a quick ratio of 1.10.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share for the quarter, topping the consensus estimate of $1.72 by $0.17. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The company had revenue of $6.05 billion during the quarter, compared to analyst estimates of $6 billion. During the same quarter last year, the firm posted $1.71 EPS. The firm’s revenue for the quarter was up 4.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Equities research analysts anticipate that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 31st. Investors of record on Friday, September 26th were issued a $0.32 dividend. The ex-dividend date of this dividend was Friday, September 26th. This represents a $1.28 annualized dividend and a yield of 0.6%. Danaher’s dividend payout ratio (DPR) is 26.39%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.